358 related articles for article (PubMed ID: 25652746)
21. The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation.
Grgic I; Lepej SZ; Lunar MM; Poljak M; Vince A; Vrakela IB; Planinic A; Seme K; Begovac J
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):329-36. PubMed ID: 22906365
[TBL] [Abstract][Full Text] [Related]
22. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
[TBL] [Abstract][Full Text] [Related]
23. Transmitted drug resistance in newly diagnosed and treatment-naïve HIV type 1-infected patients in Hungary.
Áy É; Müller V; Mezei M; Pocskay Á; Koroknai A; Müller D; Győri Z; Marschalkó M; Tóth B; Kárpáti S; Lakatos B; Szlávik J; Takács M; Minárovits J
J Glob Antimicrob Resist; 2020 Mar; 20():124-130. PubMed ID: 31330377
[TBL] [Abstract][Full Text] [Related]
24. Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.
Ong LY; Razak SN; Lee YM; Sri La Sri Ponnampalavanar S; Syed Omar SF; Azwa RI; Tee KK; Kamarulzaman A
J Med Virol; 2014 Jan; 86(1):38-44. PubMed ID: 24127302
[TBL] [Abstract][Full Text] [Related]
25. Transmitted HIV Drug Resistance in Bulgaria Occurs in Clusters of Individuals from Different Transmission Groups and Various Subtypes (2012-2020).
Alexiev I; Shankar A; Pan Y; Grigorova L; Partsuneva A; Dimitrova R; Gancheva A; Kostadinova A; Elenkov I; Yancheva N; Grozdeva R; Strashimirov D; Stoycheva M; Baltadzhiev I; Doichinova T; Pekova L; Kosmidis M; Emilova R; Nikolova M; Switzer WM
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112921
[TBL] [Abstract][Full Text] [Related]
26. Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14.
Fabeni L; Alteri C; Di Carlo D; Orchi N; Carioti L; Bertoli A; Gori C; Forbici F; Continenza F; Maffongelli G; Pinnetti C; Vergori A; Mondi A; Ammassari A; Borghi V; Giuliani M; De Carli G; Pittalis S; Grisetti S; Pennica A; Mastroianni CM; Montella F; Cristaudo A; Mussini C; Girardi E; Andreoni M; Antinori A; Ceccherini-Silberstein F; Perno CF; Santoro MM; ;
J Antimicrob Chemother; 2017 Oct; 72(10):2837-2845. PubMed ID: 29091206
[TBL] [Abstract][Full Text] [Related]
27. Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom.
Tostevin A; White E; Dunn D; Croxford S; Delpech V; Williams I; Asboe D; Pozniak A; Churchill D; Geretti AM; Pillay D; Sabin C; Leigh-Brown A; Smit E;
HIV Med; 2017 Mar; 18(3):204-213. PubMed ID: 27476929
[TBL] [Abstract][Full Text] [Related]
28. Incident and long-term HIV-1 infection among pregnant women in Brazil: Transmitted drug resistance and mother-to-child transmission.
Lima YA; Cardoso LP; Reis MN; Stefani MM
J Med Virol; 2016 Nov; 88(11):1936-43. PubMed ID: 27037910
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of HIV-1 Subtypes and Drug Resistance-Associated Mutations in HIV-1-Positive Treatment-Naive Pregnant Women in Pointe Noire, Republic of the Congo (Kento-Mwana Project).
Bruzzone B; Saladini F; Sticchi L; Mayinda Mboungou FA; Barresi R; Caligiuri P; Calzi A; Zazzi M; Icardi G; Viscoli C; Bisio F
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):837-40. PubMed ID: 25970260
[TBL] [Abstract][Full Text] [Related]
30. Origin and spread of HIV-1 in persons who inject drugs in Bulgaria.
Alexiev I; Shankar A; Dimitrova R; Gancheva A; Kostadinova A; Teoharov P; Golkocheva E; Nikolova M; Muhtarova M; Elenkov I; Stoycheva M; Nikolova D; Varleva T; Switzer WM
Infect Genet Evol; 2016 Dec; 46():269-278. PubMed ID: 27221346
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 genetic diversity and transmitted drug resistance frequency among Iranian treatment-naive, sexually infected individuals.
Vahabpour R; Bokharaei-Salim F; Kalantari S; Garshasbi S; Monavari SH; Esghaei M; Memarnejadian A; Fakhim A; Keyvani H
Arch Virol; 2017 Jun; 162(6):1477-1485. PubMed ID: 28181034
[TBL] [Abstract][Full Text] [Related]
32. Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil.
Rodrigues R; Scherer LC; Oliveira CM; Franco HM; Sperhacke RD; Ferreira JL; Castro SM; Stella IM; Brigido LF
Virus Res; 2006 Mar; 116(1-2):201-7. PubMed ID: 16332398
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil.
Cardoso LP; Pereira GA; Viegas AA; Schmaltz LE; Stefani MM
J Med Virol; 2010 Mar; 82(3):351-7. PubMed ID: 20087934
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia.
Zarandia M; Tsertsvadze T; Carr JK; Nadai Y; Sanchez JL; Nelson AK
AIDS Res Hum Retroviruses; 2006 May; 22(5):470-6. PubMed ID: 16706626
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 genetic diversity and drug resistance among treatment naïve patients from Southern Brazil: an association of HIV-1 subtypes with exposure categories.
Gräf T; Passaes CP; Ferreira LG; Grisard EC; Morgado MG; Bello G; Pinto AR
J Clin Virol; 2011 Jul; 51(3):186-91. PubMed ID: 21622023
[TBL] [Abstract][Full Text] [Related]
36. Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.
Andrade SD; Sabidó M; Monteiro WM; Benzaken AS; Tanuri A
J Antimicrob Chemother; 2017 Jun; 72(6):1774-1783. PubMed ID: 28333295
[TBL] [Abstract][Full Text] [Related]
37. HIV transmitted drug resistance in adult and pediatric populations in Panama.
Castillo J; Arteaga G; Mendoza Y; Martínez AA; Samaniego R; Estripeaut D; Page KR; Smith RE; Sosa N; Pascale JM
Rev Panam Salud Publica; 2011 Dec; 30(6):649-56. PubMed ID: 22358417
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of HIV type 1 in Brazzaville, Republic of Congo, and first data on resistance to antiretroviral drugs.
Pircher M; Diafouka M; Papuchon J; Recordon-Pinson P; Mahambou DN; Akolbout M; Simon B; Fleury H
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1798-802. PubMed ID: 22697883
[TBL] [Abstract][Full Text] [Related]
39. Low prevalence of transmitted HIV-1 drug resistance detected by a dried blood spot (DBS)-based next-generation sequencing (NGS) method in newly diagnosed individuals in Cameroon in the years 2015-16.
Mbunkah HA; Marzel A; Schmutz S; Kok YL; Zagordi O; Shilaih M; Nsanwe NN; Mbu ET; Besong LM; Sama BA; Orock E; Kouyos RD; Günthard HF; Metzner KJ
J Antimicrob Chemother; 2018 Jul; 73(7):1917-1929. PubMed ID: 29635462
[TBL] [Abstract][Full Text] [Related]
40. Antiretroviral drug resistance and HIV-1 subtypes among treatment-naive prisoners in Kelantan, Malaysia.
Ariffin TA; Mohamad S; Yusuf WN; Shueb RH
J Infect Dev Ctries; 2014 Aug; 8(8):1063-7. PubMed ID: 25116676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
